Summary: Aadi Bioscience is a biotech company focused on a nanoliposomal encapsulation of the mTOR
Summary: Today, we take our first look at a small cap oncology name called Aadi
Summary: AADI is a commercial stage company with a potential label expansion ahead. It is
Summary: Shares have lost half their value since reverse merger with Aerpio Pharmaceuticals. Aadi aims
Summary: Aadi Bioscience receives FDA approval of Fyarro for treatment of patients with PEComa. Fyarro
Summary: Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company that is developing compounds that activate Tie2
Summary: Recent “failure” of lead compound opens up new windows. Let’s talk about the pipeline;